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Correspondence Association of Cigarette Smoking
From Adolescence to Middle-Age With
Later Total and Cardiovascular Disease Mortality
The Harvard Alumni Health StudyTo the Editor: Evidence regarding the future health impact of
smoking at younger ages is usually based on retrospective
reporting of this health behavior, which demonstrates only
moderate agreement with contemporaneous reporting (1).
Studies of subsequent mortality risk with prospectively mea-
sured smoking in adolescence or early adulthood are rare and
tend to focus on total mortality (2,3). Only one study (4) has
considered cause-specific mortality, in particular cardiovascular
disease (CVD). In addition, the single baseline measure of
smoking in adolescence used in these studies is unlikely to
completely capture lifetime risk For example, there is evidence
that mortality risk in lifelong smokers versus lifelong nonsmok-
ers is far greater than that estimated for current smokers versus
nonsmokers at any individual time point (2).
Cigarette smoking in adolescence is common and continues to
ncrease. Policy makers require reliable estimates of risk disease
urden. Accordingly, we have explored all-cause, CVD, and cancer
ortality associations with cigarette smoking in early adulthood to
lder age in a large cohort of male U.S. college students. To our
nowledge, this duration of lifetime prospective measurement of
igarette smoking is unrivaled in the literature.
The Harvard Alumni Health Study is an ongoing cohort study
f male alumni from Harvard University who entered college
etween 1916 and 1950. Cigarette smoking status was obtained at
aseline during a medical examination, and comparable smoking
ata were also reported in follow-up surveys in 1962/1966, 1977,
nd 1988. We explored baseline smoking associations with mor-
ality to the end of 1998 from: 1) all causes, 2) CVD, 3) cancers
elated to smoking, and 4) cancers not related to smoking, using
ox proportional hazards regression. We also examined the
ssociations of all-cause mortality with continuing smoking status
ased on smoking status collected at baseline and in 1962/1966,
977, and 1988. Men were defined as continuing nonsmokers
nonsmoker at all 4 time points), continuing smokers (current
mokers at all 4 time points), or quitters (current smoker at
aseline and nonsmoker by 1988 with only 1 change in status).
en who changed their smoking status more than once or took up
moking during follow-up were omitted from these analyses.
here were too few deaths to explore cause-specific mortality in
his context.
Of 33,415 men in the original cohort, 28,236 (84.5%) had data on
igarette smoking at baseline (mean age 18 years). Baseline charac-
eristics of men included and excluded from analyses were similar.
verall, 10,253 men (36.3%) smoked at baseline, although the
roportion of smokers varied according to the decade of interview:
pproximately one-quarter of men interviewed in the 1910s werecigarette smokers, and this proportion increased steadily to 40.6% in
the 1940s before decreasing to 34.3% in the 1950s. After a median
follow-up period of 53.2 (range: 0.3 to 83.5) years, 13,704 men
(48.5%) had died. Men reporting that they smoked cigarettes at
baseline experienced a 30% (95% confidence interval [CI]: 26% to 35%)
increase in mortality from all causes (Table 1) compared with those
who were nonsmokers. Mortality for specific causes was also
increased in men who were smokers at baseline. As anticipated,
this was most marked for smoking-related cancers (hazard ratio
[HR]: 1.91; 95% CI: 1.72 to 2.12), and there was also a clear 20%
(14% to 27%) increase in CVD mortality in men who smoked in
early adulthood.
Analysis of continuing smoking status was based on 5,785 men
with complete data on smoking at baseline, 1962/1966 (mean
age 42 years), 1977 (mean age 55 years), and 1988 (mean age 66
years). At baseline, 2,269 (39.2%) of these men were cigarette
smokers, and the impact of smoking was similar to that in the
full cohort. Among baseline smokers, 1,303 (57.4%) were still
smoking in 1966, 573 (25.3%) were still smoking in 1977, and only
253 (11.1%) were continuing smokers in 1988. Mortality in
continuing smokers was more than double that in continuing
nonsmokers (HR: 2.11; 95% CI: 1.63 to 2.74), while mortality
in men who smoked at baseline but subsequently quit was
higher than in continuing nonsmokers but markedly lower than in
those who continued to smoke (HR: 1.29; 95% CI: 1.15 to 1.46).
The negative health effects of cigarette smoking are well
understood, yet smoking rates in young people are continuing to
rise. The link between adolescent smoking and later mortality
has been little examined, particularly in the context of CVD
mortality. Although adolescent smoking patterns in our cohort
may differ from those of contemporary adolescents, our results
indicate that cigarette smoking reported directly in early adult-
hood has a negative impact on mortality, particularly due to
CVD and smoking-related cancers, more than 50 years later.
Although exposure prevalence may differ, there is every reason
to anticipate that these smoking-mortality results have contem-
porary relevance and they are consistent with other evidence
(2–4). Changing smoking rates by baseline year track the
increasing popularity of cigarette smoking during the first half
of the 20th century, followed by a decline in uptake as negative
health effects became more widely understood in the 1960s. It
is interesting that almost 90% of baseline smokers had quit by
1988, reflecting increasing public health information during
this period. The beneficial effects of quitting smoking, as seen
previously (5), are clear, with the excess mortality reduced in
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October 30, 2012:1839–43those who quit in comparison with those who continued to
smoke. Health education should be targeted at preventing
smoking uptake in young people and encouraging current
mokers to quit.
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Table 1
Hazard Ratio (95% Confidence Interval) for
Baseline and Continuing Smoking Status (T
Men With Baseli
(N  2
N (Alive/Died)
All cause
Baseline smoking
Nonsmoker 9,419/8,564
Cigarette smoker 5,113/5,140
p Value
Continuing smoking†
Continuing nonsmoker
Continuing smoker
Quit during follow-up
p Value
CVD‡
Baseline smoking
Nonsmoker 14,290/3,693
Cigarette smoker 8,287/1,966
p Value
Smoking-related cancer‡,§
Baseline smoking
Nonsmoker 17,222/761
Cigarette smoker 9,562/691
p Value
Nonsmoking-related cancer‡,§
Baseline smoking
Nonsmoker 16,750/1,233
Cigarette smoker 9,617/636
p Value
*Adjusted for age at baseline examination and year of baseline exam
exercise, alcohol at baseline, and socioeconomic status in 1988 had
1962/1966, 3) 1977, and 4) 1988. ‡There were too few deaths to e
considered to be related to smoking were lung, oral cavity, nasopha
esophagus, stomach, pancreas, liver, kidney (body and pelvis), ureter,
considered not to be related to smoking.
CI  confidence interval; CVD  cardiovascular disease; HR  hazaational Institutes of Health (CA130068 and DK081141). This is report No. XCVIn a series on chronic disease in former college students. All other authors have
eported they have no relationships relevant to the contents of this paper to
isclose.
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